Zum Hauptinhalt springen

Buprenorphin

14. Oktober 2025 | Buprenorphin

Evaluating Treatment Options for Opiate Use Disorder: A Meta-Analysis of Buprenorphine-Naloxone and Extended-Release Naltrexone.

Evaluating Treatment Options for Opiate Use Disorder: A Meta-Analysis of Buprenorphine-Naloxone and Extended-Release Naltrexone. Awaji BH, Abanmi SN, Alqahtani MS, Alhodathi L, Alrehaili M, Aldohan TF, Alkhenaizan AS, Alsughayer ZM, Alyahya A…

14. Oktober 2025 | Buprenorphin

Feasibility of direct induction onto long-acting injectable buprenorphine.

Feasibility of direct induction onto long-acting injectable buprenorphine. Naren T, Membrey D, MacCartney P, D'Cunha R, Nielsen S, Garry S. J Subst Use Addict Treat. 2025 Sep 16;179:209808. doi: 10.1016/j.josat.2025.209808. Epub ahead…

04. Oktober 2025 | Buprenorphin

Perspectives and experiences with sleep and recovery among women receiving buprenorphine for opioid use disorder.

Perspectives and experiences with sleep and recovery among women receiving buprenorphine for opioid use disorder. Eglovitch M, Parlier-Ahmad AB, Patev AJ, Cook B, Shi C, Violante S, Dzierzewski JM, James MH, Martin CE. PLOS Ment Health…

04. Oktober 2025 | Buprenorphin

Employment and Long-Acting Injectable Buprenorphine for Opioid Use Disorder: Findings from Longitudinal Qualitative Interviews Conducted with Patients Recruited from Drug Treatment Services.

Employment and Long-Acting Injectable Buprenorphine for Opioid Use Disorder: Findings from Longitudinal Qualitative Interviews Conducted with Patients Recruited from Drug Treatment Services. Neale J, Cosgrove S, Cassidy J, Strang J. Su…

04. Oktober 2025 | Buprenorphin

Innovative Approaches to Buprenorphine Initiation Amid the Overdose Crisis-Injecting Hope.

Innovative Approaches to Buprenorphine Initiation Amid the Overdose Crisis-Injecting Hope. Suen LW, Rosenwohl-Mack S. JAMA Netw Open. 2025 Aug 1;8(8):e2527020. doi: 10.1001/jamanetworkopen.2025.27020. PMID: 40815517. https://jamanetwo…

27. September 2025 | Buprenorphin

Removing arbitrary limitations on buprenorphine for opioid use disorder.

Removing arbitrary limitations on buprenorphine for opioid use disorder. Gastala, N., Hudak, B., Pho, M.T., Pollack, H.A. and Wilcox, K. (2025), Addiction, 120: 1913-1915. doi.org/10.1111/add.70127 https://onlinelibrary.wiley.com/doi/…

27. September 2025 | Buprenorphin

Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experience.

Extended-release buprenorphine treatment for opioid use disorder: A mixed-methods study of response and experience. Lowry N, McKechnie A, Day E, Gilvarry E, Cowden F, Evans R, et al. Addiction. 2025; …

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten